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Abstract
Background: Some children with congenital heart diseases (CHD) may have increased pulmonary blood flow that causes
recurrent bronchopneumonia and congestive heart failure. Serum zinc is reduced in children with pneumonia and patients
on diuretics.
Objective: To evaluate the serum zinc level of  children with CHD and their controls without CHD.
Method: The subjects were 41 children with CHD confirmed on echocardiography recruited from a paediatric cardiology
clinic in a tertiary centre in Nigeria. The controls were 41 children without CHD. Biodata and anthropometric measurements
were taken. The serum zinc was determined using atomic absorption spectrophotometer method.
Result: The mean difference in the serum zinc of the subjects 101.3 ±  21.6µg/dl and controls 106.5 ± 18.3µg/dl, was not
significant, p = 0.351.The subjects with pneumonia had a lower mean serum zinc value 89.5 ± 15.0µg/dl compared to those
without pneumonia 103.9  ± 22.2µg/dl, p = 0.006. The mean serum zinc values of the subjects on diuretic was not
statistically different from those not on diuretic, p = 0.599.
Conclusion: The serum zinc levels of the subjects and controls were not significantly different. Children with CHD and
pneumonia had significantly lower zinc level compared to those without pneumonia.
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Congenital heart diseases (CHD) are the commonest
congenital anomalies accounting for 8/1000 live
births globally1 and 6 – 8/ 1000 live births in children
in Nigeria2. They are a cause of chronic ill health and
a significant cause of mortality in children especially
in developing countries where there are non-existent
or limited capacity for surgical and percutanoeus
interventions3,4.
 Zinc an intracellular ion which is an
antioxidant, is essential for the activity of many
enzymes such as angiotensin converting enzyme and
the matrix metalloproteinases5. Zinc has been shown
to be involved in growth and development; its
deficiency is associated with higher prevalence of
pneumonia6 and diarrhea7 in children while pregnant
mothers deficient in zinc have been shown to have a
higher prevalence of babies with CHD8.
The CHD with left to right shunt are
associated with pulmonary overcirculation. This
predisposes to recurrent bronchopneumonia and
congestive heart failure (CHF)9. The septal defects
such as ventricular septal defect (VSD),
atrioventricular septal defect (AVSD) and Patent
ductus arteriosus (PDA) are examples of  such
anomaly. Bronchopneumonia and CHF may affect
serum zinc level in several ways; studies have shown
that children with pneumonia have significantly lower
serum zinc values compared to their counterparts
without pneumonia6,10. The diuretic therapy in
patients with heart failure causes zincuria11. The
thiazide and angiotensin converting enzyme inhibitors
are more likely to cause zincuria than other medicines
used for CHF12,13.
 In resource poor countries, because the
capacity for surgical interventions for children with
CHD is limited, most of these children live with
chronic heart failure and the recurrent
bronchopneumonia which may predispose them to
zinc depletion. Recurrent episodes of
bronchopneumonia may cause low zinc and the low
zinc levels may further predispose to
bronchopneumonia setting up a vicious circle.
Besides, children with CHD are prone to low serum
zinc levels because of poor intake and absorption
arising from malnutrition which they are prone to14.
As part of the management of these patients
with CHD who also have chronic heart failure and
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recurrent pneumonia, they are placed on anti-failure
medications involving diuretics and ACE inhibitors.
Recurrent antibiotic treatment amongst other
medicines is also required. The cost of these
medicines has been shown to be a cause of
socioeconomic burden to their parents15.
This study was undertaken to evaluate the
serum zinc level in children with CHD compared to
age and sex matched controls without CHD. The
study also seeks to identify factors influencing serum
zinc levels in these children.
Methods
The study was carried out in the Paediatric Cardiology
out- patient clinic of a tertiary hospital in Nigeria. A
convenient sample size of 41 subjects and 41 controls
were recruited. The subjects were clinically stable
children with congenital heart disease (CHD)
attending the clinic with an inclusion criterion that
the last febrile illness was at least two weeks before
the day of recruitment. Serum zinc levels are low
following febrile illnesses. An informed verbal
consent was obtained from the accompanying
parent(s). The diagnosis of the CHD was made on
clinical ground, typical findings on chest radiograph
and electrocardiogram. The diagnosis was confirmed
on echocardiography done by one of the
investigators (WES). The controls were age and sex
matched children who either attended or
accompanied their parents to the immunization clinic
and patients who were followed up in the clinics for
febrile illnesses (malaria, pharyngitis and acute otitis
media). In all cases, any febrile illness would have
resolved at least two weeks prior to the day of
recruitment. The children had a thorough systemic
examination particularly looking for signs of CHD
such as finger clubbing, cyanosis, suffused
conjunctivae, abnormal heart sound (such as fixed
and wide splitting of the second heart sound) and
presence of  murmur. The controls had
echocardiography to exclude CHD.
Patients in the clinic with chronic heart failure
are placed on hydrochlorthiazide and spironolactone.
Captopril and Digoxin were included in severe cases.
These patients also received antibiotic when they had
pneumonia. Patients with TOF are placed on
propanolol. All the patients are seen from monthly
clinic schedule to other time interval as deemed
appropriate. Other treatments were offered as
required. The study was carried out between March
and August 2011.
A proforma was used to collect
information on biodata, socioeconomic class (SEC)
and the presence and time since last febrile illness.
The SEC was determined by the methods described
by Olusanya et al16. The drug profile of the patients
on medicines for heart failure and the occurrence
of bronchopneumonia (including frequency) were
determined from review of  the casenotes. It was
noted if  the patient had cyanotic or acyanotic CHD.
The patients’ weight was measured using a
bassinet weighing scale for infant and an appropriate
weighing scale for older children, the height/ length
was measured with a standiometer or an
infantometer as appropriate, using standard methods.
The Z scores of the weight for age were computed
using the WHO growth charts for children17.
Malnutrition was defined using the Z scores of
weight for age thus; children with z scores < -2 SD
were malnourished, well nourished children were
those with Z score between -2 and +2 SD and
overweight children had z scores > +2 SD.
Following aseptic procedure, 3 ml of  blood
was drawn from each patient, it was spun, the serum
decanted and stored in a refrigerator at a temperature
of -400. Once recruitment was completed, the serum
samples were prepared for serum Zinc analysis using
the modified Dogan el al method18. The serum Zinc
was then analyzed for using atomic absorption
spectrophotometer (AAS, Varian Spectra AA10
model). Three separate analyses for Zinc were done
on each sample and the mean of the three Zinc
values was recorded.
Ethical approval was obtained from the
University Of  Benin Teaching Hospital Ethics
Committee.
Statistical analysis
The data were entered into an SPSS spread sheet
and analyzed with SPSS version 16.0. IL Chicago.
The means of continuous variable such as age,
weight, height and serum Zn were compared with
student’s t test, multiple means were compared with
one way ANOVA.  The association between non
parametric variables was tested with Pearson’s chi
square test. Statistically significant p value was taken
as <0.05.
Results
There were 41 subjects with congenital heart disease
recruited for the study with 41 age and sex matched
controls. There were 21(51.2%) males and 20(48.8%)
females each of  subjects and controls. The ages for
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the subjects and control ranged between 6 weeks and 17
years. The subjects were further classified into age groups
thus; <1 year 11(26.8%), 1 - <5 years 21(51.2%), 5 - <10
years 5(12.2%) and >10 years 4(9.8%). The mean age, weight
and height of the subjects were not significantly different
from those of the controls. The details of the study
characteristics are shown in table I. Two subjects did not
have enough information to assess their socioeconomic
status. The distribution of the subjects and controls by
their socioeconomic classes are shown in table 1.
Table 1: Characteristics of  the study population
Characteristic                    Subject               Control          P value
Mean age (years)                 3.5 ± 4.3                3.6 ± 4.8        0.914
Mean weight (kg)               13.2 ± 10.6             14.4 ± 13.1     0.671
Mean height (cm)               90.2 ± 10.7             91.3 ± 30.6     0.869
Gender
Male                        21                          21
Female                                 20                          20              1.000
Socioeconomic class
High                                     14                         12
Middle                                  13                        16              0.797
Low                                      12                        13
Thirty one (75.6 %) of the subjects had acyanotic
CHD while 10 (23.4%) had cyanotic CHD. The
diagnoses of the subjects are shown in table 2.
Ventricular septal defect either isolated or in
combination with other cardiac defects 22(53.6 %)
was the commonest acyanotic CHD while Tetralogy
of Fallot 7(17.1 %) was the commonest cyanotic
CHD.  There were 10(24.4%) subjects who were in
chronic heart failure and were thus on diuretics,
3(30%) of those on diuretic were also on digoxin
and captopril. Seventeen (41.5%) subjects had had
bronchopneumonia. The distribution of
bronchopneumonia episodes since birth showed that
7(41.2%), 4(23.5%), 4(23.5%) and 2(11.8%) of the
17 children had had bronchopneumonia once, twice,
four times and thrice times respectively. Of  those
with bronchopneumonia, 1(5.9 %) had cyanotic
CHD (truncus arteriosus) while 16(94.1%) had
acyanotic CHD.
The mean Zn level in the subjects was 101.3
± 21.6 µg/dl with a range of 67.3 – 156.2 µg/ dl.
This was not statistically different from the mean
level in the control 106.5 ± 18.3 (range 69.9 – 139.9)
µg/dl, p = 0.351. The mean serum zinc level was
highest 102.6 ± 30.7 µg/dl in youngest age group <
1 year and lowest 94.8 ± 12.4 µg/dl in the oldest
age group >10 years. The mean serum zinc values
of subjects aged 1 - <5 year and 5 - <10 years were
100.7 ± 19.6 and 97.4 ± 16.3 µ/dl respectively. The
differences in the mean serum zinc values were
however not statistically significant, p = 0.932.
The mean Zn levels in subjects who had
bronchopneumonia 89.5 ± 15.0 µg/ dl was
significantly lower than the value obtained in subjects
who did not have bronchopneumonia 103.9 ± 22.2
µg/ dl, p = 0.0006. There was no significant gender
and socioeconomic class differences in the mean Zn
levels of subjects, p = 0.937 and p = 0.754
respectively. The mean serum Zn levels of  subjects
who were on diuretic for chronic heart failure and
those not on diuretic was not statistically different, p
= 0.599. Although subjects who were malnourished
had lower mean serum Zn value 95.4 ± 24.8 µg/dl,
than those with normal nutritional status, the
difference was not statistically significant, p = 0.654.
Table 3 shows the mean Zn levels according to the
subjects socio-demographic and clinical
characteristics.
Table 2: Type of  congenital heart disease in
subjects
Type of CHD        Number           %
Isolated VSD             19                    46.3
VSD and ASD             1                    2.4
VSD and PDA             2                    4.9
TOF                           7                    17.1
AVSD                         5                    12.2
Isolated ASD               3                     7.4
TA                             2                      4.9
TGA                          1                      2.4
Isolated PDA              1                      2.4
VSD = ventricular septal defect, ASD = atrial septal
defect, PDA = patent ductus arteriosus, TOF =
tetralogy of  Fallot, AVSD = atrio-ventricular septal
defect, TA = truncus arteriosus and TGA =
transposition of  great arteries.
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Table 3: Mean serum zinc values of  subjects by some socio-demographic and
clinical characteristics
Characteristics               Mean Zinc (µg/dl)     p value
Gender
Males                               98.0 ± 23.5
Females                            98.7 ± 19.0                 0.937
Type of CHD
Cyanotic                           91.5 ± 19.0
Acyanotic                         103.9 ± 22.2               0.144
Bronchopneumonia
Present                              89.5 ± 15.0
Absent                              103.9 ± 22.2              0.0006
Diuretic therapy
On diuretic                        95.4 ± 17.0
Not on diuretic                  100.0 ± 22.9              0.599
Nutritional status
Malnutrition                        95.4 ± 24.8
Normal nutritional status      99.3 ± 19.6              0.654
Socioeconomic class
High SEC                           95.4 ± 14.4
Middle SEC                        102.6 ± 25.5            0.754
Low SEC                           99.3 ± 27.5
Table 4 shows the mean serum zinc levels by type
of  CHD. The lowest value was obtained in patients
with Truncus arteriosus 80.4 ± 13.1 µg/dl and the
highest was in atrio-ventricular septal defect 105.9 ±
41.2 µg/dl. There is no significant correlation
between the subjects’ age, height and weight with
the serum Zn values. (r = -0.059, p = 0.727; r = -
0.07, p = 0.679; r = -0.114, p = 0.502 respectively)
No correlation was noted for the controls with
respect to age height and weight.
Table 4: The mean serum zinc values of  the different congenital heart diseases
Type of CHD  (n)                            Mean Zn level (µg/dl)
Isolated and combined VSD (24)         103.9 ± 19.0
TOF and TGA (8)                              94.8 ± 19.6
AVSD (4)                                           105.9 ± 41.2
ASD (3)                                             98.0 ± 15.0
TA (2)                                                80.4 ± 13.1
Discussion
The subjects who had bronchopneumonia had
significantly lower zinc values compared to those
who did not have bronchopneumonia. Considering
that zinc level was determined in these children after
their zinc status should have normalized, the findings
in this study highlights the role zinc plays in acting as
acute phase reactant in bronchopneumonia thus
leading to its depletion in children with CHD and
pneumonia. In a Turkish study6, children younger
than two years with pneumonia had significantly
lower serum zinc than their aged matched control
without pneumonia. Kumar et al19 in India, showed
that the blood zinc level of children with severe
pneumonia was significantly lower than age, sex and
nutritional status matched controls. CHD patients
with pneumonia may thus be particularly susceptible
to zinc depletion even after they are supposed to
have recovered from acute pneumonia.
The subjects on diuretic for the treatment
of chronic CHF had lower serum zinc values
compared to subjects who were not on diuretic. The
difference did not reach statistical significance. This
is consistent with some studies that did not show
any significant difference in the serum zinc level of
volunteers on frusemide and hydrochlorthiazide12,20.
However, the serum zinc levels of children with
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congestive heart failure was found to be significantly
lower than their age and sex matched controls in a
study by Atlihan and co-workers20. The difference
in findings in the two studies may be due to patients
characteristics, the patients in the Atlihan study, were
recruited during the acute phase of heart failure while
in the present study the children were evaluated at
least two weeks after the acute heart failure episode.
This would have allowed time for the partial
restoration of  zinc in patients in the present study.
The lower zinc levels in patients with cardiac failure
can be attributed to the zincuric effect of the diuretic
use. The patients in this study were on
hydrochlorthiazide and spiranolactone. Although
thiazide therapy is associated with zinc depletion; that
some patients were also on digoxin may have
mitigated the zincuria effect of  the diuretics. The
reversal of zinc depletion by digoxin was
demonstrated in a study on children with heart failure.
The lower serum zinc level initially noted in patients
with heart failure when compared to their controls
increased significantly following digoxin therapy21.
Another medicine that would have
accentuated the zinc depletion in the management
of  CHF is the ACE inhibitor captopril. Most of  the
patients were not on captopril (this was prior to the
inclusion of  ACE inhibitor to the treatment of  CCF
as standard practice in the centre) and the additional
zinc depletion from this medicine could not be
evaluated. Captopril is particularly associated with
zinc depletion because zinc is an important co-
enzyme in the activity of angiotensin converting
enzyme.  To properly evaluate the effect of  diuretic
therapy and ACE inhibitor, a controlled study
involving children with chronic heart failure on
medication for a long duration perhaps may yield
more inferences.
The distribution of the malnourished and
well nourished children in both the subjects and
controls was not significantly different. Thus the
differences noted in the serum zinc values among
subject with and without certain characteristics may
not have been due to the well known effect of
malnutrition on serum zinc status of the study
subjects22. It is of note that all the children including
the malnourished ones had normal serum zinc levels.
It is possible that sources of zinc in their diet are
common to both children with CHD and those
without CHD. The local cereals that the under-fives
are fed are commonly fortified with groundnut, a
good source of zinc.
From the study, cyanotic CHD subjects had
a higher serum zinc level compared to those with
acyanotic CHD. This result could be due to the very
low serum zinc values obtained in the patients with
truncus arteriosus who had the lowest serum zinc
levels compared to the other CHDs. This may have
contributed to the lower serum zinc value in Cyanotic
CHD. Truncus arteriosus is a cyanotic CHD with
increased pulmonary overcirculation and thus prone
to bronchopneumonia and CHF. In fact the two
patients with truncus arteriosus had 3 – 4 episodes
of bronchopneumonia prior to the study and were
being managed for chronic CHF. This finding again
underscores the fact that associated
bronchopneumonia is a major contributor to the
low zinc values obtained in these patients compared
to the value in patients with other types of  CHDs.
Conclusion
The serum zinc level of children with CHD was not
significantly lower than in controls. The presence of
acute bronchopneumonia in children with CHD and
the presence of truncus arteriosus were associated
with zinc reduction in this study.
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